Safety and Immunotherapeutic Activity of Cemiplimab in Participants With HBV on Suppressive Antiviral Therapy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Debika Bhattacharya, MD
UCLA CARE Center CRS
Study Chair - Jordan Feld, MD, PhD
University Health Network / Toronto Centre for Liver Disease
Study Chair - Raymond T. Chung, MD
Massachusetts General Hospital CRS
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- 12201, Hospital Nossa Senhora Da Conceicao Crs
Porto Alegre, Brazil
- 12101, Instituto de Pesquisa Clinica Evandro Chagas (ipec) Crs
Rio de Janeiro, Brazil
- Toronto General Hospital Crs
Toronto, Ontario, Canada
- Thai Red Cross Aids Research Centre (trc-Arc) Crs (site # 31802)
Bangkok, Thailand
- Chiang Mai University Hiv Treatment (cmu Hiv Treatment) Crs (site Id: 31784)
Chiang Mai, Thailand
- Ucsf Hiv/aids Crs
San Francisco, California, United States
- the Ponce de Leon Center Crs
Atlanta, Georgia, United States
- Massachusetts General Hospital Crs (mgh Crs)
Boston, Massachusetts, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Jan 2024
- Primary completion
- 30 Sept 2027
- Completion
- 30 Sept 2027
- Last update posted
- 7 Sept 2023
- Registered enrollment
- 0
- Registry id
- NCT04046107
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.